BioWorld

Aug. 16, 2002

ImClone Files $7M Suit Against Sam Waksal, Reports Earnings

ImClone Systems Inc. filed a lawsuit against its founder and former CEO, Sam Waksal, claiming he destroyed documents possibly relevant to a government investigation of the company's business practices. (BioWorld Today) Read More

Genaera Reduces Staff To Focus On Select Products

Texas Soil Yields Molecule Of Unprecedented Power; Ecopia, Academics Domesticating It

Ribozyme Expands Focus, Cuts Staff By 30 Employees

MedImmune Enters Deals With Biosite, ViroNovative

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...